Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Aliment Pharmacol Ther ; 47(8): 1126-1134, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29512187

ABSTRACT

BACKGROUND: Case series suggest a possible association between bariatric surgery and incident IBD. AIM: The aim of this study was to evaluate the association between bariatric surgery and new-onset IBD. METHODS: We first conducted a multi-institutional case series of patients with a history of IBD and bariatric surgery. We next conducted a matched case-control study using medical and pharmacy claims from 2008 to 2012 in a US national database from Source Healthcare Analytics LLC. Bariatric surgery was defined by ICD-9 or CPT code. Bariatric surgery was evaluated as recent (code in database timeframe), past (past history V code) or no history. Conditional logistic regression was used to estimate odds ratios (OR) and 95% CI for new-onset IBD, CD and UC. RESULTS: A total of 15 cases of IBD (10 CD, 4 UC, 1 IBD, type unclassified) with a prior history of bariatric surgery were identified. Most cases were women, had Roux-en-Y surgery years prior to diagnosis and few IBD-related complications. A total of 8980 cases and 43 059 controls were included in our database analysis. Adjusting for confounders, a past history of bariatric surgery was associated with an increased risk of new-onset IBD (OR 1.93, 95% CI 1.34-2.79). However, patients who had recent bariatric surgery did not appear to be at shorter term risk of IBD (OR 0.94, 95% CI 0.58-1.52). CONCLUSION: New-onset IBD was significantly associated with a past history of bariatric surgery. This potential association needs to be confirmed in future prospective studies.


Subject(s)
Bariatric Surgery/adverse effects , Inflammatory Bowel Diseases/etiology , Adolescent , Adult , Case-Control Studies , Databases, Factual , Female , Humans , Inflammatory Bowel Diseases/epidemiology , Logistic Models , Male , Middle Aged , Odds Ratio
2.
Acta Gastroenterol Belg ; 76(2): 235-40, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23898562

ABSTRACT

BACKGROUND AND STUDY AIMS: Complicated Acute Colonic Diverticulitis (ACD) is usually treated by parenteral way thus keeping the bowel at rest. To date there are no clear recommendations regarding the route of nutrition administration. We study the safety of early feeding by oral energetic fiber-free liquid diet in non-surgical complicated ACD patients. PATIENTS AND METHODS: From February 2008 to October 2011, 25 patients were admitted with complicated ACD and took part in this prospective study. Surgical and medical assessments were performed at admission. Initial treatment was given with perfusion, intravenous antibiotics and hydric diet. Within 72 hours of admission, antibiotic therapy was switched to oral administration for 5 up to 15 days depending on the progression of the disease. At the same time the patient received oral liquid fiber-free feeding. Solid but fiber-free diet was introduced 24h hours before discharge. RESULTS: 25 cases of ACD were complicated with covered perforation and/or abscess. Mean hospitalisation time was 10A.4 days. 23 cases had good recovery and discharged, while 1 case progressed to colonic stenosis during hospitalisation, requiring a sigmoidectomy with a one-time anastomosis with good recovery. One patient relapsed his abscess during hospitalisation despite CT guided drainage and required sigmoidectomy with transient ileostomy. The mean daily treatment and nutrition cost for the non-surgical 23 patients was 30 euros. CONCLUSIONS: Early enteral nutrition in complicated ACD is feasible, not harmful, and reduce both, mean hospitalization time and treatment cost. Further studies comparing enteral with parenteral nutrition are necessary to confirm our hypothesis.


Subject(s)
Diverticulitis, Colonic/diet therapy , Energy Intake , Enteral Nutrition/adverse effects , Acute Disease , Adult , Aged , Aged, 80 and over , Dietary Fiber , Diverticulitis, Colonic/diagnosis , Enteral Nutrition/methods , Feasibility Studies , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prospective Studies , Retrospective Studies , Risk Factors , Time Factors
3.
Acta Gastroenterol Belg ; 61(2): 268-70, 1998.
Article in English | MEDLINE | ID: mdl-9658623

ABSTRACT

Hepatorenal syndrome is a rapidly lethal complication of cirrhosis. The present case provides further evidence of the efficacy of terlipressin in this context even with concomitant treatment with propranolol. A 56 year old male with HBV related cirrhosis developed renal failure characteristic of hepatorenal syndrome. He was also taking propranolol for primary prophylaxis of variceal bleeding. Terlipressin 6 mg/day was administered during haemodialysis and after 1 week plasma creatinine dropped from 6.2 to 2.8 mg%. Daily urinary volume, plasma sodium and natriuresis dramatically increased during the treatment. Discontinuation of the treatment led to a rapid relapse of renal failure (plasma creatinine from 1.8 to 2.2 mg%) and the drug was readministered until a successful liver transplantation could be performed 1 month after the beginning of the treatment. The patient has now a near normal renal function 3 months after transplantation.


Subject(s)
Antihypertensive Agents/therapeutic use , Hepatorenal Syndrome/drug therapy , Hepatorenal Syndrome/surgery , Liver Transplantation , Lypressin/analogs & derivatives , Propranolol/therapeutic use , Combined Modality Therapy , Drug Therapy, Combination , Follow-Up Studies , Humans , Lypressin/therapeutic use , Male , Middle Aged , Terlipressin
4.
Acta Gastroenterol Belg ; 60(3): 243-5, 1997.
Article in English | MEDLINE | ID: mdl-9396184

ABSTRACT

We report the case of a patient admitted to the hospital with psychiatric troubles. Soon after admission, he presented severe hepatitis of unknown origin. Careful review of the charts, transvenous liver biopsy, right heart and hepatic pressure measurements, negative toxicologic and viral screenings were highly suggestive of hypoxic hepatitis. Indeed, the patient had previously been treated for a decompensated cardiomyopathy and medications stopped prior to the current admission. Without clear clinical evidence of heart failure he presented a brief malaise two days before the increase in liver enzymes. Holter heart recording showed afterwards bouts of ventricular tachycardia. Treatment with Dobutamine and antiarrythmics led to a rapid decrease of transaminase levels and recovery in liver function. Unfortunately, he died three weeks later from his cardiomyopathy. This case illustrates the need for cardiovascular work-up in the context of hepatitis from unknown origin.


Subject(s)
Heart Failure/complications , Hepatitis/complications , Hepatitis/enzymology , Mental Disorders/etiology , Transaminases/blood , Adrenergic beta-Agonists/therapeutic use , Aged , Biopsy, Needle , Diagnosis, Differential , Dobutamine/therapeutic use , Fatal Outcome , Heart Failure/diagnosis , Heart Failure/drug therapy , Hepatitis/pathology , Hepatitis/therapy , Humans , Liver Function Tests , Male , Transaminases/drug effects
5.
Acta Gastroenterol Belg ; 55(3): 285-94, 1992.
Article in English | MEDLINE | ID: mdl-1378677

ABSTRACT

From March 87 to March 92, fifty eight patients were referred to our department for percutaneous endoscopic gastrostomy (PEG). The modality of the feeding tube insertion is described. The most common indications for placement were neurologic disorders in 62% of the cases (n = 36) and malignant diseases in 32% (n = 19). The success rate of the technique was 98.3% (n = 57). No procedure-related mortality was observed. A low rate of major complication (1.7%) and minor complication (10.5%) was noted. Feeding tubes were removed in 21% of patients (n = 12); none of them with malignant disease. Survival curve analysis demonstrated that 50% of patients died within 3 months of PEG placement. Such results raise questions about the selection of patients undergoing PEG. Our experience of patients undergoing PEG. Our experience suggests that PEG is easy and safe, even in debilitated patients, having an acceptable life expectancy.


Subject(s)
Gastroscopy/methods , Gastrostomy/methods , Central Nervous System Diseases/therapy , Enteral Nutrition/methods , Gastrostomy/adverse effects , Gastrostomy/mortality , Humans , Neoplasms/therapy , Palliative Care , Retrospective Studies
6.
Acta Gastroenterol Belg ; 55(2): 169-75, 1992.
Article in French | MEDLINE | ID: mdl-1632133

ABSTRACT

Recent advances in the instrumentation and techniques of enteroscopy now permit examination of the small bowel. This report is on the use of a prototypic small bowel enteroscopy to investigate patients with gastrointestinal bleeding of obscure origin. We used the sonde-type enteroscope (Olympus Corp.) that migrates distally responding to peristaltic activity. This instrument has neither tip deflection controls nor interventional capability. Small bowel enteroscopy was performed in 17 patients. Arteriovenous malformations were visualized in 5 patients but three of them suffered from Rendu-Osler disease. Small bowel enteroscopy can be useful in the evaluation of patients with gastrointestinal bleeding of obscure origin. However, patients must be well selected on basis of negative routine examinations because this method is time-consuming.


Subject(s)
Endoscopy, Gastrointestinal/methods , Gastrointestinal Hemorrhage/diagnosis , Adult , Aged , Aged, 80 and over , Arteriovenous Malformations/diagnosis , Endoscopes, Gastrointestinal , Female , Gastrointestinal Hemorrhage/etiology , Humans , Intestine, Small/blood supply , Middle Aged , Telangiectasia, Hereditary Hemorrhagic/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...